Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)

STO:NEWBRY Balance Sheet

Financials in millions SEK. Fiscal year is September - August.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 28, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021
Cash & Equivalents	12.86	15.3	8.53	33.33	13.15
Cash & Short-Term Investments	12.86	15.3	8.53	33.33	13.15
Cash Growth	100.52%	79.44%	-74.42%	153.59%	-
Accounts Receivable	-	15.24	9.12	0	1.08
Other Receivables	21.06	7.01	6.39	0.79	1.25
Receivables	21.06	22.25	15.51	0.79	2.33
Inventory	6.93	5	2.11	1.77	-
Prepaid Expenses	-	1.42	1.09	0.58	0.29
Total Current Assets	40.85	43.97	27.24	36.47	15.77
Goodwill	-	1.26	2.13	3.04	3.95
Other Intangible Assets	46.83	45.64	43.55	47.39	23.09
Total Assets	87.67	90.87	72.92	86.91	42.81
Accounts Payable	-	1.94	4.28	2.04	1.88
Accrued Expenses	-	6.28	3.19	0.89	2.23
Current Income Taxes Payable	-	0.08	0.16	0.18	0.07
Current Unearned Revenue	-	-	1.63	-	-
Other Current Liabilities	33.73	21.14	2.52	2.96	0.16
Total Current Liabilities	33.73	29.45	11.77	6.06	4.34
Other Long-Term Liabilities	9.16	9.51	11.77	12.08	-
Total Liabilities	42.89	38.95	23.54	18.14	4.34
Common Stock	44.78	0.77	0.62	0.62	0.16
Additional Paid-In Capital	-	106.72	88.71	88.71	43.89
Comprehensive Income & Other	-	-55.58	-39.96	-20.57	-5.58
Shareholders' Equity	44.78	51.92	49.38	68.77	38.47
Total Liabilities & Equity	87.67	90.87	72.92	86.91	42.81
Net Cash (Debt)	12.86	15.3	8.53	33.33	13.15
Net Cash Growth	100.52%	79.44%	-74.42%	153.59%	-
Net Cash Per Share	0.54	0.71	0.44	1.87	-
Filing Date Shares Outstanding	24.26	24.26	19.52	19.52	15.68
Total Common Shares Outstanding	24.26	24.26	19.52	19.52	15.68
Working Capital	7.12	14.53	15.47	30.42	11.43
Book Value Per Share	1.85	2.14	2.53	3.52	2.45
Tangible Book Value	-2.04	5.02	3.7	18.34	11.43
Tangible Book Value Per Share	-0.08	0.21	0.19	0.94	0.73

Source: S&P Global Market Intelligence. Standard template. Financial Sources.